- $59.01m
- $58.90m
- $1.32m
Annual income statement for Agape ATP, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3.45 | 1.02 | 1.86 | 1.43 | 1.32 |
| Cost of Revenue | |||||
| Gross Profit | 2.68 | 0.72 | 1.19 | 0.937 | 0.759 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3.61 | 2.88 | 3.39 | 3.58 | 3.9 |
| Operating Profit | -0.158 | -1.86 | -1.53 | -2.15 | -2.57 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.516 | -2.39 | -1.67 | -2.11 | -2.48 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.355 | -2.52 | -1.67 | -2.11 | -2.49 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.355 | -2.52 | -1.69 | -2.1 | -2.47 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.355 | -2.52 | -1.69 | -2.1 | -2.47 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.019 | -0.134 | -0.382 | -0.554 | -0.633 |